Atractylenolide Ⅰ ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase Ⅰ and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway
YUAN Jianan CHENG Kunming LI Chao ZHANG Xiang DING Zeyu LI Bing ZHENG Yongqiu
中医杂志（英文版）2025，Vol.45Issue(1)：57-65,9.
中医杂志（英文版）2025，Vol.45Issue(1)：57-65,9.DOI:10.19852/j.cnki.jtcm.2025.01.006
Atractylenolide Ⅰ ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase Ⅰ and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway
Atractylenolide Ⅰ ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase Ⅰ and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway
摘要
关键词
atractylenolide Ⅰ/post-infectious irritable bowel syndrome/polymerase Ⅰ and transcript release factor/network pharmacology/MAP kinase signaling system/nitric oxide synthase type ⅡKey words
atractylenolide Ⅰ/post-infectious irritable bowel syndrome/polymerase Ⅰ and transcript release factor/network pharmacology/MAP kinase signaling system/nitric oxide synthase type Ⅱ引用本文复制引用
YUAN Jianan,CHENG Kunming,LI Chao,ZHANG Xiang,DING Zeyu,LI Bing,ZHENG Yongqiu..Atractylenolide Ⅰ ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase Ⅰ and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway[J].中医杂志（英文版）,2025,45(1):57-65,9.基金项目
The University Collaborative Innovation Project of Anhui:Creation of a Combined Animal Model of Coronary Heart Disease based on the Theory of Xin'an Medicine(No.GXXT-2020-024) （No.GXXT-2020-024）
Start-up Funding for Doctoral Research at Wannan Medical College(WYRCQD2018009) （WYRCQD2018009）
Horizontal Project of South Anhui Medical College(H202003) （H202003）
